# DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)

> **NCT04709705** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cellphire Therapeutics, Inc.** · enrollment: 161 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **BIOLOGICAL:** Human platelets

## Key facts

- **NCT ID:** NCT04709705
- **Lead sponsor:** Cellphire Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-27
- **Primary completion:** 2025-05-08
- **Final completion:** 2025-05-08
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04709705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04709705, "DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04709705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*